PEG 10 promotes the migration of human Burkitt's lymphoma cells by up-regulating the expression of matrix metalloproteinase-2 and-9

Clinical and Investigative Medicine

Volumn 35, Issue 3, 2012, Pages

  Xiong, Jie ^a   Qin, Jian ^b   Zheng, Yingcheng ^a   Peng, Xiaofan ^a   Luo, Yixing ^a   Meng, Xiangyu ^a  

^a WUHAN UNIVERSITY   (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; FLUOROURACIL; GELATINASE A; GELATINASE B; PEG10 PROTEIN, HUMAN; PROTEIN; SMALL INTERFERING RNA;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; BURKITT LYMPHOMA; CELL MOTION; CELL STRAIN HEK293; DRUG EFFECT; ENZYMOLOGY; FLOW CYTOMETRY; HUMAN; PATHOPHYSIOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; UPREGULATION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; BURKITT LYMPHOMA; CELL LINE, TUMOR; CELL MOVEMENT; FLOW CYTOMETRY; FLUOROURACIL; HEK293 CELLS; HUMANS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; UP-REGULATION;

EID: 84865406935     PISSN: 0147958X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kelly GL, Rickinson AB: Burkitt lymphoma: revisiting the pathogenesis of a virus-associated malignancy. Hematology Am Soc Hematol Educ Program 2007:277-284.
2. Griffin TC, Weitzman S, Weinstein H, Chang M, Cairo M, Hutchison R, Shiramizu B, Wiley J, Woods D, Barnich M et al: A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group. Pediatr Blood Cancer 2009, 52(2):177-181.
3. Ono R, Kobayashi S, Wagatsuma H, Aisaka K, Kohda T, Kaneko-Ishino T, Ishino F: A retrotransposon-derived gene, PEG 10, is a novel imprinted gene located on human chromo some 7q21. Genomics 2001, 73(2):232-237.
4. Li CM, Margolin AA, Salas M, Memeo L, Mansukhani M, Hib-shoosh H, Szabolcs M, Klinakis A, Tycko Bi. PEG10 is a c-MYC target gene in cancer cells. Cancer Res. 2006, 15;66(2):665-672.
5. Tsou AP, Chuang YC, Su JY, Yang CW, Liao YL, Liu WK, Chiu JH, Chou CK: Overexpression of a novel imprinted gene, PEG 10, in human hepatocellular carcinoma and in regenerating mouse livers. J Biomed Sci 2003,10(6 Pt l):625-635.
6. Okabe H, Satoh S, Furukawa Y, Kato T, Hasegawa S, Nakajima Y, Yamaoka Y, Nakamura Y: Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1. Cancer Res 2003, 63(12):3043-3048.
7. Steplewski A, Krynska B, Tretiakova A, Haas S, Khalili K, Amini S: MyEF-3, a developmentally controlled brain-derived nuclear protein which specifically interacts with myelin basic protein proximal regulatory sequences. Biochem Biophys Res Commun 1998, 243(l):295-301.
8. Ono R, Nakamura K, Inoue K, Naruse M, Usami T, Wakisaka-Saito N, Hino T, Suzuki-Migishima R, Ogonuki N, Miki H et al: Deletion of PeglO, an imprinted gene acquired from a retro-transposon, causes early embryonic lethality. Nat Genet 2006, 38(l):101-106.
9. Smallwood A, Papageorghiou A, Nicolaides K, Alley MK, Jim A, Nargund G, Ojha K, Campbell S, Banerjee S: Temporal regu lation of the expression of syncytin (HERV-W), maternally im printed PEG10, and SGCE in human placenta. Biol Reprod 2003,69(l):286-293.
10. Kainz B, Shehata M, Bilban M, Kienle D, Heintel D, Kromer-Holzinger E, Le T, Krober A, Heller G, Schwarzinger I et al.: Overexpression of the paternally expressed gene 10 (PEG 10) from the imprinted locus on chromosome 7q21 in high-risk B-cell chronic lymphocytic leukemia. Int J Cancer 2007, 121(9):1984-1993.
11. Chunsong H, Yuling H, Li W, Jie X, Gang Z, Qiuping Z, Qing-ping G, Kejian Z, Li Q, Chang AE et al: CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23+CD5+ B cells. J Immunol 2006, 177(10):6713-6722.
12. Mazzucchelli L, Blaser A, Kappeler A, Scharli P, Laissue JA, Baggiolini M, Uguccioni M: BCA-1 is highly expressed in Heli-cobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest 1999, 104(10):R49-54.
13. Smith JR, Braziel RM, Paoletti S, Lipp M, Uguccioni M, Rosen-baumJT: Expression of B-cell-attracting chemokine 1 (CXCL13) by malignant lymphocytes and vascular endothe-lium in primary central nervous system lymphoma. Blood 2003, 101(3):815-821.
14. McDonnell S, Morgan M, Lynch C: Role of matrix metallopro-teinases in normal and disease processes. Biochem Soc Trans 1999,27(4):734-740.
15. Morgan M, Kniss D, McDonnell S: Expression of metalloprote-inases and their inhibitors in human trophoblast continuous cell lines. Exp Cell Res 1998, 242(1): 18-26.
16. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM: Ma trix metalloproteinases: biologic activity and clinical implica tions. J Clin Oncol 2000,18(5):1135-1149.
17. Janowska-Wieczorek A, Marquez LA, Matsuzaki A, Hashmi HR, Larratt LM, Boshkov LM, Turner AR, Zhang MC, Ed wards DR, Kossakowska AE: Expression of matrix metalloprote inases (MMP-2 and -9) and tissue inhibitors of metalloprote inases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells. Br J Haematol 1999,105(2):402-411.
18. Stetler-Stevenson M, Mansoor A, Lim M, Fukushima P, Kehrl J, Marti G, Ptaszynski K, Wang J, Stetler-Stevenson WG: Expres sion of matrix metalloproteinases and tissue inhibitors of metal loproteinases in reactive and neoplastic lymphoid cells. Blood 1997,89(5):1708-1715.
19. Shi Y, Yang DH, Xiong J, Jia J, Huang B, Jin YX: Inhibition of genes expression of SARS coronavirus by synthetic small inter fering RNAs. Cell Res 2005,15(3): 193-200.
20. Chintala SK, Tonn JC, Rao JS: Matrix metalloproteinases and their biological function in human gliomas. Int J Dev Neurosci 1999,17(5-6):495-502.
21. Goetzl EJ, Banda MJ, Leppert D: Matrix metalloproteinases in immunity. J Immunol 1996, 156(l):l-4.
22. Ries C, Loher F, Zang C, Ismair MG, Petrides PE: Matrix metal-loproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Clin Cancer Res 1999, 5(5):1115-1124.